CLINICAL TRIALS PROFILE FOR DESMOPRESSIN ACETATE
✉ Email this page to a colleague
All Clinical Trials for DESMOPRESSIN ACETATE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00111215 ↗ | Treatment and Management of Women With Bleeding Disorders | Completed | Centers for Disease Control and Prevention | N/A | 2001-01-01 | The purpose of the study is to determine whether oral contraceptives, desmopressin acetate, and/or tranexamic acid are effective in the treatment of women with menorrhagia who are diagnosed with a bleeding disorder. |
NCT00477490 ↗ | Efficacy and Safety of Desmopressin Melt for the Treatment of Nocturia | Completed | Ferring Pharmaceuticals | Phase 3 | 2007-05-01 | The purpose of this study is to investigate the efficacy and safety of several doses of the melt formulation of desmopressin in a broad population of adult patients with nocturia. |
NCT00835211 ↗ | Desmopressin Acetate 0.2 mg Tablets, Fasting | Completed | Teva Pharmaceuticals USA | Phase 1 | 2003-07-01 | The objective of this study was to compare the single-dose relative bioavailability of TEVA and Aventis Pharmaceuticals (DDAVP®) 0.2 mg desmopressin acetate tablets following a 0.8 mg dose under fasting conditions. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for DESMOPRESSIN ACETATE
Condition Name
Clinical Trial Locations for DESMOPRESSIN ACETATE
Trials by Country
Clinical Trial Progress for DESMOPRESSIN ACETATE
Clinical Trial Phase
Clinical Trial Sponsors for DESMOPRESSIN ACETATE
Sponsor Name